High efficacy of fludarabine-containing therapy (FLAG-FLANG) in poor risk acute myeloid leukemia

Cattedre di Ematologia, Azienda Ospedale S. Martino e Cliniche Universitarie convenzionate, Genoa, Italy. BACKGROUND: Elderly patients with acute myeloid leukemia (AML) those refractory to induction chemotherapy and those with so-called secondary leukemia have unfavorable prognoses and require innov...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Haematologica (Roma) 1996-11, Vol.81 (6), p.513-520
Hauptverfasser:	Clavio, M, Carrara, P, Miglino, M, Pierri, I, Canepa, L, Balleari, E, Gatti, AM, Cerri, R, Celesti, L, Vallebella, E, Sessarego, M, Patrone, F, Ghio, R, Damasio, E, Gobbi, M
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Disease Adult Aged Antineoplastic agents Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biological and medical sciences Chemotherapy Cytarabine - administration & dosage Cytarabine - adverse effects Female Granulocyte Colony-Stimulating Factor - administration & dosage Granulocyte Colony-Stimulating Factor - adverse effects Humans Karyotyping Leukemia, Myeloid - drug therapy Leukemia, Myeloid - genetics Leukemia, Myeloid - pathology Male Medical sciences Middle Aged Mitoxantrone - administration & dosage Mitoxantrone - adverse effects Pharmacology. Drug treatments Prognosis Treatment Outcome Vidarabine - administration & dosage Vidarabine - adverse effects Vidarabine - analogs & derivatives
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!